Regulatory

Anuncia Wins FDA Breakthrough Status for ReFlow® EVD

With its expanded ReFlow® portfolio, Anuncia targets improved ICU outcomes, reduced surgical interventions, and greater global access to CSF management—from U.S. hospitals to underserved regions in Africa....

Subtle Medical’s AI-Powered SubtleHD™ Secures CE Mark, Bringing Faster, Higher-Quality MRI Imaging to Europe

Innovative software enhances MRI scan quality, reduces scan times by up to 80%, and optimizes radiology workflows without requiring hardware upgrades. ...

Boulder iQ Executives to Share Fast-Track Strategies for MedTech Innovation at LSI USA 25

Industry leaders Jim Kasic and Larry Blankenship to present time- and cost-efficient approaches for accelerating medical device development and market entry. ...

Spinal Resources Inc. Secures Patent for Bezier Parametric Curve Spinal Rod System

Innovative Spinal Rod Technology Enhances Surgical Flexibility and Patient-Specific Customization ...

Baird Medical Gains Indonesian Regulatory Approval for Microwave Ablation Technology

Approval paves the way for broader adoption of Baird Medical’s minimally invasive treatment for tumor ablation, expanding access to advanced cancer care in Indonesia. ...

Beckman Coulter Secures FDA Clearance for DxC 500i Clinical Analyzer

The integrated clinical chemistry and immunoassay system enhances efficiency, streamlines lab workflows, and delivers accurate diagnostics in a compact design....

SkinCure Oncology Submits GentleBeam™ for FDA Clearance, Expanding Noninvasive Skin Cancer Treatment

GentleBeam™ aims to enhance Image-Guided SRT for nonmelanoma skin cancer, reinforcing SkinCure Oncology’s commitment to patient-centered, nonsurgical care. ...

Zimmer Biomet Wins FDA Nod for Metal-Safe Knee Implant

Zimmer Biomet Secures FDA Clearance for Persona® Revision SoluTion™ Femur, Expanding Options for Metal-Sensitive Knee Implant Patients...

Optellum and Volpara Health Partner to Enhance AI-Driven Cancer Risk Assessment

Strategic agreement integrates Optellum’s AI-powered lung nodule analysis with Volpara’s early cancer detection tools, enabling a more comprehensive approach to patient risk evaluation....

NAMSA acquires WuXi AppTec’s US medical device testing operations to expand expertise and capacity

The acquisition strengthens NAMSA’s leadership in medical device biological safety testing, adding expertise, lab capacity, and scientific resources to support global manufacturers....